PATRICIA STARK: Open Payments
NPI 1558320697 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 63 payments from 16 companies in 2025. Trend: 2023 $744 · 2024 $915 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $393 |
| Lilly USA, LLC | 14 | $182 |
| Novo Nordisk Inc | 4 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| PFIZER INC. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 1 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: VRAYLAR, QULIPTA, Ozempic, JARDIANCE, FARXIGA, MOUNJARO, UBRELVY, GEMTESA.
Industry payments across TX — which companies pay providers there.
